8-70706999-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001011720.2(XKR9):c.339C>A(p.Phe113Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,613,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001011720.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKR9 | NM_001011720.2 | c.339C>A | p.Phe113Leu | missense_variant | 4/5 | ENST00000408926.8 | NP_001011720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XKR9 | ENST00000408926.8 | c.339C>A | p.Phe113Leu | missense_variant | 4/5 | 1 | NM_001011720.2 | ENSP00000386141 | P1 | |
XKR9 | ENST00000520030.5 | c.339C>A | p.Phe113Leu | missense_variant | 5/6 | 1 | ENSP00000431088 | P1 | ||
XKR9 | ENST00000520273.1 | n.198C>A | non_coding_transcript_exon_variant | 2/4 | 3 | |||||
XKR9 | ENST00000520092.5 | c.*79C>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/6 | 2 | ENSP00000430781 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251054Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135702
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1461086Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 726842
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2023 | The c.339C>A (p.F113L) alteration is located in exon 4 (coding exon 2) of the XKR9 gene. This alteration results from a C to A substitution at nucleotide position 339, causing the phenylalanine (F) at amino acid position 113 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at